N/A
Manufactured by Rite Aid Corporation
148 FDA adverse event reports analyzed
Last updated: 2026-04-15
LIDOCAINE AND MENTHOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Rite Aid Corporation. The most commonly reported adverse reactions for LIDOCAINE AND MENTHOL include DRUG INEFFECTIVE, NO ADVERSE EVENT, PAIN, PNEUMONIA, APPLICATION SITE PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LIDOCAINE AND MENTHOL.
Out of 60 classified reports for LIDOCAINE AND MENTHOL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 148 FDA FAERS reports that mention LIDOCAINE AND MENTHOL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, NO ADVERSE EVENT, PAIN, PNEUMONIA, APPLICATION SITE PAIN, DIZZINESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Rite Aid Corporation in connection with LIDOCAINE AND MENTHOL. Always verify the specific product and NDC with your pharmacist.